|
|
|
| IMIQUIMOD | |||
|
PRODUCT IDENTIFICATION |
|||
| CAS NO. | 99011-02-6 |
|
|
| EINECS NO. | |||
| FORMULA | C14H16N4 | ||
| MOL WT. | 240.31 | ||
|
H.S. CODE |
|||
|
TOXICITY |
| ||
| SYNONYMS | 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; | ||
| 4-Amino- 1-isobutyl-1H-imidazo[4,5-c] quinoline; | |||
| SMILES |
|
||
|
CLASSIFICATION |
|||
|
PHYSICAL AND CHEMICAL PROPERTIES |
|||
| PHYSICAL STATE | white crystalline powder | ||
| MELTING POINT | 289 - 291 C | ||
| BOILING POINT | |||
| SPECIFIC GRAVITY | |||
| SOLUBILITY IN WATER | Soluble | ||
| pH | |||
| VAPOR DENSITY |
| ||
| AUTOIGNITION |
|
||
| NFPA RATINGS |
|
||
|
REFRACTIVE INDEX |
|||
| FLASH POINT |
|
||
| STABILITY |
Stable under ordinary conditions | ||
|
APPLICATIONS |
|||
| Imiquimod ,
an imidazoquinolinamine, is a an immune response modifier as
a potential
antiviral and anti-tumour agent stimulating the release of
nonantibody protein called cytokine, a generic term of soluble peptides
(molecular weight less than 100 kilodaltons) that are released by some cells on
contact with specific antigen to act as intercellular mediators and as in the
generation of an immune response, serving as intercellular signals. Imiquimod is
used to treat external warts called condyloma acuminatum and to treat a skin
condition of the face and scalp called actinic keratoses. Imiquimod is a white
crystalline powder melting at 290 C. Chemical designation is
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine.
|
|||
| SALES SPECIFICATION | |||
|
APPEARANCE |
white crystalline powder | ||
|
IDENTIFICATION |
Complies Test A,B |
||
| ASSAY |
99.0% min |
||
|
LOSS ON DRYING |
1.0% max |
||
|
RELATED SUBSTANCE |
0.5% max |
||
|
HEAVY METALS |
10ppm max |
||
| SULFATED ASH |
0.1% max |
||
| TRANSPORTATION | |||
| PACKING |
|
||
| HAZARD CLASS | |||
| UN NO. | |||
| OTHER INFORMATION | |||
| Hazard Symbols: XI, Risk Phrases: 36/37/38, Safety Phrases: 26-36 | |||
|
|
|
